In 2023, the European sold production of composite diagnostic or laboratory reagents exhibited significant variations across countries. Ireland leads with a substantial volume of 814.07 million kilograms, followed by Finland and Denmark, with notable year-on-year increases of 128.4% and 132.05% respectively. Germany and Italy also showed growth, though more modest at 1.91% and 15.33%. The Netherlands witnessed a remarkable 57.21% increase. Spain and France grew by 8.02% and 7.52%, while the UK experienced a slight decline of 0.62%. Smaller markets like Lithuania, Greece, and Croatia showed moderate positive growth, whereas Slovakia and Estonia either saw declines or stagnation.
In terms of future trends, there is an anticipation of continued growth in the composite diagnostic or laboratory reagents market, driven by advancements in healthcare technology and increased demand for diagnostic services. Countries with significant current production, like Ireland and Germany, are expected to maintain or even enhance their output, while smaller markets may see increased production capacity and market share due to ongoing investments and innovations within the sector.
Top countries in Sold Production of Composite Diagnostic or Laboratory Reagents by Country
| # | 10 Countries | Kilograms | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Ireland | 814,070,000 | 2021 | View data | ||
| 2 | 2 Finland | 49,551,000 | 2023 | +43.14% | +128.4% | View data |
| 3 | 3 Denmark | 38,445,000 | 2023 | +46.69% | +132.05% | View data |
| 4 | 4 Germany | 19,493,000 | 2023 | +3.02% | +1.91% | View data |
| 5 | 5 Austria | 15,528,000 | 2021 | +6.83% | View data | |
| 6 | 6 Italy | 13,256,000 | 2023 | +10.06% | +15.33% | View data |
| 7 | 7 France | 10,741,000 | 2023 | +2.33% | +7.52% | View data |
| 8 | 8 Netherlands | 8,181,100 | 2023 | +45.34% | +57.21% | View data |
| 9 | 9 Spain | 6,344,400 | 2023 | +2.3% | +8.02% | View data |
| 10 | 10 United Kingdom | 5,892,200 | 2023 | -0.88% | -0.62% | View data |
